ANNOUNCEMENT {#s1}
============

Acinetobacter baumannii is a Gram-negative, opportunistic pathogen from the genus Acinetobacter and a member of the family Moraxellaceae. It is a serious and emerging pathogen that causes nosocomial and community-acquired infections in humans, with a high incidence among immunocompromised patients ([@B1]). In animals, it is associated with mastitis, wound infections, septicemia, bronchopneumonia, and eye infections. Horses have been reported to develop wound infections, septicemia, and bronchopneumonia, as well as neonatal encephalopathy and eye infections ([@B2]).

A. baumannii strain 161514 was isolated in Germany in 2016 from a horse with conjunctivitis. The sample was a part of a resistance monitoring system aimed at collecting resistance data on animal-pathogenic bacteria (GERM-Vet-2016). The sample was cultured on Columbia blood agar at 37°C, and initial microbial species identification was done using matrix-assisted laser desorption ionization--time of flight mass spectrometry (MALDI-TOF MS; Bruker Daltonik GmbH, Bremen, Germany) and PCR by detection of the *bla*~OXA-51-like~ carbapenemase gene ([@B3]).

MICs were determined by the microdilution method using the Micronaut MDR large animal 3, MRGN-screening 3, and β-lactamase plates (Merlin Diagnostika GmbH, Bornheim-Hersel, Germany). The susceptibility to the panel of antimicrobial agents was determined as described in the manufacturer's instructions and interpreted automatically according to the CLSI guidelines ([Table 1](#tab1){ref-type="table"}).

###### 

Genetic features of Acinetobacter baumannii isolate 161514, recovered from a horse

  Parameter[^*a*^](#ngtab1.1){ref-type="table-fn"}   Value
  -------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Total no. of reads                                 1,399,296
  Avg read length (range \[bp\])                     250.2 (35--301)
  No. of reads after trimming                        1,284,782
  No. of contigs                                     22
  *N*~50~ (bp)                                       474,099
  Largest contig size (bp)                           1,006,808
  Genome coverage (×)                                108
  Genome                                             
      Size (bp)                                      3,839,365
      GC content (%)                                 38.93
  Genetic elements                                   
      Total no. of genes                             3,657
      Total no. of CDS                               3,587
      No. of coding genes                            3,529
      No. of coding CDS                              3,529
      No. of RNA genes                               70
      No. of rRNAs (5S, 16S, 23S)                    1, 1, 1 (draft)
      No. of tRNAs                                   63
      No. of tmRNAs                                  1
      No. of ncRNAs                                  4
      Total no. of pseudogenes                       58
  MLST results                                       
      Abaumannii1 (Oxford)                           ST462 (Oxf_gdhB_59 A\>T)
      Abaumannii2 (Pasteur)                          ST46
  Database accession no.                             
      GenBank                                        [RPDK00000000](https://www.ncbi.nlm.nih.gov/nuccore/RPDK00000000)
      BioProject                                     [PRJNA505595](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA505595)
      BioSample                                      [SAMN10426731](https://www.ncbi.nlm.nih.gov/biosample/SAMN10426731)
  Genetic resistance determinants                    
      β-Lactams (%)                                  *bla*~OXA-104~ (100), *bla*~OXA-203~ (99.88), *bla*~OXA-ADC25~ (95.94), *bla*~ADC-76-1777~ (96.88), *bla*~A1-1063~ (91.64), *bla*~A2-1542~ (97.1), *bla*~MBL-329~ (96.7), *bla*~OXA-203-719~ (99.88)
      Efflux pumps                                   AdaAB, AdaIJK, and AdaFGH
  Phenotypic resistance (MIC \[mg/liter\])           
      Ampicillin                                     16
      Azetronam                                      \>16
      Cefoperazone                                   32
      Ceftiofur                                      \>4
      Cephalothin                                    \>128
      Erythromycin                                   \>4
      Florfenicol                                    \>128
      Fosfomycin                                     \>64
      Penicillin G                                   \>32
      Spectinomycin                                  \>64
      Tiamulin                                       \>64
      Tilmicosin                                     64
      Tulathromycin                                  64
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CDS, coding sequences; tmRNA, transfer-messenger RNA; ncRNA, noncoding RNA; MLST, multilocus sequence typing.

Genomic DNA was extracted according to the manufacturer's instructions using the Qiagen Genomic-tip 100/G kit (Qiagen, Hilden, Germany) from a single colony grown in LB medium supplemented with 1% glucose at 37°C. The paired-end sequencing library was prepared with the Nextera XT DNA library prep kit (Illumina, Inc., San Diego, CA, USA). The library was sequenced using a MiSeq sequencer (Illumina, Inc.). Raw reads were processed using the shovill pipeline v1.04 (<https://github.com/tseemann/shovill>) to produce assembled FASTA files of more than 500 bp in length and with a kmer coverage greater than 3 (enabled options, -trim, -minlen 500, -mincov 3). Quality assessment of the assembled data was conducted with QUAST v4.3 using standard settings ([@B4]). Genome annotation was performed using PGAP v4.9 and the NCBI database ([@B5]). The distribution of genes (including resistance genes) assigned to the SEED subsystems and the initial metabolic reconstruction were analyzed using RAST ([@B6]) ([Table 1](#tab1){ref-type="table"}). Multilocus sequence typing (MLST) of the assembled A. baumannii 161514 sequence was performed using both the Oxford and Pasteur schemes ([@B7], [@B8]) ([Table 1](#tab1){ref-type="table"}). The prevalence of antimicrobial resistance (AMR) genes and variants organized by antibiotic resistance ontology phenotype classification was determined with Resistance Gene Identifier (RGI) v4.2.0 (DIAMOND homolog detection) based on the Comprehensive Antibiotic Resistance Database (CARD) v2.0.3 ([@B9]). The AMR genes and/or chromosomal mutations in the isolated strain were determined using the SRST2 tool v0.2.0 ([@B10]) and the databases ResFinder v3.1 ([@B11]) and ARG-ANNOT ([@B12]) ([Table 1](#tab1){ref-type="table"}). Default parameters were used for all software tools unless stated differently.

Acinetobacter baumannii is a serious and emerging pathogen that causes nosocomial and community-acquired infections in humans. The data on the impact of A. baumannii strains from (companion) animal origin on human health are still inconclusive. Further comprehensive studies are needed to assess the possible zoonotic risk of this agent for human and animal health.

Data availability. {#s1.1}
------------------

The sequence data of A. baumannii 161514 were deposited in the NCBI archive under GenBank accession number [RPDK00000000](https://www.ncbi.nlm.nih.gov/nuccore/RPDK00000000), SRA accession number [SRR8191030](https://www.ncbi.nlm.nih.gov/sra/SRR8191030), BioProject accession number [PRJNA505595](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA505595), and BioSample accession number [SAMN10426731](https://www.ncbi.nlm.nih.gov/biosample/?term=SAMN10426731).
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